• WSIC receives funding in the European IMAGIO research consortium

    The European research consortium IMAGIO "Imaging and Advanced Guidance for workflow optimization in Interventional Oncology" is funded with 24 million euros by the Innovative Health Initiative (IHI). The Department of Preclinical Imaging and Radiopharmacy (Prof. Dr. Bernd Pichler) is part of this consortium.

    Read more

  • WSIC receives 18.4 million euros in funding from the Werner Siemens Foundation

    The Werner Siemens Imaging Center (WSIC) at the Radiological University Hospital Tübingen and the Medical Faculty of the University of Tübingen is pleased to announce that it has received a total of 18.4 million euros in funding from the Swiss Werner Siemens Foundation (WSS)

    Read more

  • Innovative method to improve cancer immunotherapy

    The Preclinical Imaging and Radiopharmacy Department of the University Hospital Tübingen and ImaginAb, a global market leading biotech company, are cooperating in the field of cancer immunotherapy making Tübingen Europe's first center for the production of radiolabeled CD8 minibodies.

    Read more